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Despite improvements in genomics technology, the detection of structural variants (SVs)
from short-read sequencing still poses challenges, particularly for complex variation. Here we
analyse the genomes of two patients with congenital abnormalities using the MinION
nanopore sequencer and a novel computational pipeline—NanoSV. We demonstrate that
nanopore long reads are superior to short reads with regard to detection of de novo chro-
mothripsis rearrangements. The long reads also enable efficient phasing of genetic variations,
which we leveraged to determine the parental origin of all de novo chromothripsis break-
points and to resolve the structure of these complex rearrangements. Additionally, genome-
wide surveillance of inherited SVs reveals novel variants, missed in short-read data sets, a
large proportion of which are retrotransposon insertions. We provide a first exploration of
patient genome sequencing with a nanopore sequencer and demonstrate the value of long-
read sequencing in mapping and phasing of SVs for both clinical and research applications.
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Second-generation DNA sequencing has become an essentialtechnology for research and diagnosis of human geneticdisease. Sequencing of human exomes has resulted in dra-
matic increases in novel gene discovery for Mendelian disorders1,
while whole-genome sequencing has revealed that a myriad of
diseases are caused by genetic changes that can occur both within
genes as well as in the noncoding genome2. As a result, genome
sequencing has seen rapid adoption in clinical decision making,
as the complete picture of a patient’s unique mutation profile
enables personalization of treatment strategies3,4.
Robust methods to detect structural variants (SVs) in human
genomes are essential, as SVs represent an important class of
genetic variation that accounts for a far greater number of vari-
able bases than single nucleotide variations (SNVs)5. Moreover,
SVs have been implicated in a wide range of genetic disorders6.
A particularly revolutionary development in genome sequen-
cing is the use of protein nanopores to measure DNA sequence
directly and in real time7. The first successful implementation of
this principle in a consumer device was achieved in 2014 by
Oxford Nanopore Technologies (ONT) with the introduction of
the MinION8. The MinION can sequence stretches of DNA of up
to hundreds of kilobases in length, which already resulted in the
sequencing of the genomes of several organisms9,10. Because
MinION-based sequencing requires almost no capital investment
and current devices have a very small footprint, mainstream
adoption of these sequencers has the potential to fundamentally
change the current paradigm of sequencing in centralized centers.
An important and natural application of the long reads pro-
duced by nanopore sequencing is identifying SVs. Long-read
sequencing is breaking ground for the discovery of SVs at an
unprecedented scale and depth11. The first success has been
achieved using the Pacific BioSciences SMRT long-read sequen-
cing platform12,13, and alternative methods to capture long-range
information have been introduced, such as BioNano optical
mapping14 and 10× Genomics linked-read technology15. While
short-read next-generation sequencing data rely on multiple
(often) indirect sources of information in order to accurately
identify SVs, structural changes can be directly reflected in long-
read data.
In this work, we demonstrate sequencing of the whole diploid
human genomes of two patients on the MinION sequencer at
11–16× depth of coverage. The two patients suffer from con-
genital disease resulting from complex chromothripsis. We
employ a novel computational pipeline to demonstrate the fea-
sibility of using MinION reads to detect de novo complex SV
breakpoints, at high sensitivity. The long reads from the MinION
allow efficient phasing of genetic variations (SNVs as well as SVs)
and enable us to resolve the long-range structure of the chro-
mothripsis in the patients. Moreover, we identify a significant
proportion of SVs that are not detected in short-read Illumina
sequencing data of the same patient genomes.
Results
Sequencing of patient genomes with nanopore MinION. As a
first step toward real-time clinical genome sequencing, we eval-
uated the use of the MinION device to sequence the genomes of
two patients with multiple congenital abnormalities16, henceforth
denoted as Patient 1 and Patient 2, respectively.
We extracted DNA from patient cells and sequenced this on
the MinION. For Patient 1, we used R7, R9, and R9.4 pore
chemistries (Supplementary Table 1) generating a total of 8.2M
template sequencing reads from 122 sequencing runs. For Patient
2, we exclusively used R9.4 runs and performed only 13 runs
(1.89M reads), which required ~5 days of sequencing on seven
parallel MinION instruments at a cost of around $7000
(Supplementary Fig. 1), and produced a coverage of 11×. We
observed that 82.1% (Patient 1) and 98.9% (Patient 2) of these
reads could be mapped to the human reference genome and were
useful for further analyses. Read lengths were highly variable for
Patient 1, as a result of differences in library prep methods, with a
mean of 6.9 kb for template reads, while for Patient 2 we reached
an average of 16.2 kb with consistent read-length distributions
across each of the 13 runs (Supplementary Fig. 2).
Raw sequencing data were transformed into FASTQ format
using Poretools and sequence reads were mapped to the human
reference genome (GRCh37) using LAST17. We uniquely aligned
99% of R7/R9 2D reads or R9.4 1D reads flagged as “passed” after
EPI2ME base calling, while this dropped to 55% for R9-based
“failed” 2D reads (Supplementary Fig. 3). We evaluated the
mapping accuracy by calculating the percentages of identical bases
(PID) between mapped reads and the reference genome. We
observed a mean PID of 90% for R7 2D and R9 2D, 85% for R9
template and 89% for R9.4 template reads based on LAST
mapping (Supplementary Fig. 4). An analysis of error rates and
types, within the Patient 2 data (i.e., R9.4 reads only), shows that
from an observed per-base error rate of 15.1%, indel errors were
the dominant error class (10%: 9.1% deletions, 0.9% insertions),
followed by mismatches (5.1%). We found a 2.6-fold increase
in deletion errors for sequences overlapping homopolymers
and 1.4-fold for sequences overlapping tandem repeats
(Supplementary Fig. 5). Furthermore, both deletion and mismatch
rates were increased in regions with high GC content
(Supplementary Fig. 6).
We obtained a mean coverage depth of 16× and 11× for Patient
1 and Patient 2, respectively (Supplementary Fig. 7). Coverage
was lower in regions with higher GC content, yet this effect was
much less pronounced than for the Illumina sequencing data of
the same genomes (Supplementary Fig. 8)12. This finding was
confirmed by analysis of k-mer distributions of MinION data
(Supplementary Fig. 9). We note that while the MinION reads
marked as “fail” show systematic sequencing biases regarding
coverage distribution, the quality of the aligned fraction is
comparable to the “pass” reads. We therefore included the “fail”
data of Patient 1 that was successfully retrieved through
alignment, in all subsequent analyses.
Resolving de novo genomic rearrangements with long-read
data. Both patients have complex phenotypes involving dys-
morphic features and mental retardation, likely caused by their de
novo complex chromosomal rearrangements, which were kar-
yotypically defined as 46,XX,ins(2;9)(q24.3;p22.1p24.3)dn
(Patient 1) and 46,XY,t(1;9;5)(complex)dn (Patient 2)16.
We evaluated the performance to detect the breakpoints
underlying the complex de novo karyotypes of Patient 1 and
Patient 2 using MinION sequencing data, at this medium
coverage. Both patients have already been described in recent
work, in which Illumina sequencing was used to map the
rearrangement breakpoints, as the current gold-standard method
for routine genome-wide SV mapping in patient genomes16,18.
For Patient 1, we augmented the previously described data by
performing Illumina HiSeq X data for both parents. We
performed SV calling with Delly19 and Manta20 on the Illumina
data from Patient 1 and its parents. By integrating SV calls from
Delly and Manta and removing calls that were also identified in
one or both parents, we obtained a set of 44 putative de novo SV
breakpoints, 40 of which formed a complex genomic rearrange-
ment, as described previously16. These 40 breakpoints were
verified by orthogonal breakpoint assays using PCR and MiSeq
sequencing (Supplementary Table 2). The breakpoints cluster
within regions of chromosomes 2, 7, 8, and 9 and are the result of
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a complex shattering and reassembly process, known as
chromothripsis21,22 (Fig. 1a).
For Patient 2, there were 29 SVs underlying the complex de
novo karyotype as based on the previously described breakpoint
junctions, which were detected using long-insert mate-pair
sequencing and revealed a complex chromothriptic rearrange-
ment involving chromosomes 1, 5, and 9 (Fig. 1a and
Supplementary Table 2)16.
To enable SV detection in nanopore long-read sequencing
data, we developed a new bioinformatic tool, NanoSV, tailored to
nanopore data. NanoSV uses split read mapping (obtained
from LAST alignment) as a basis for SV discovery (“Methods”
section and Supplementary Fig. 10), and supports discovery
of all defined types of SVs (Supplementary Fig. 11).
The performance of NanoSV was first evaluated on simulated
nanopore long-read data of an artificially rearranged
chromosome and benchmarked against two other recently
published SV callers, Lumpy23 and Sniffles24. We thus
generated 501 simulated rearrangement breakpoints on
chromosome 1 and generated equal amounts of simulated
nanopore reads of the rearranged, as well as the reference
chromosome, using NanoSim25 (“Methods”). We assessed
performance of NanoSV, Lumpy, and Sniffles on these simulated
data with varying read coverage (1× to 44×). We observed that
NanoSV reaches 99.2% recall at 27× coverage (Supplementary
Fig. 12) with a maximum false positive rate of 1.2% (at 44×
coverage). For Lumpy and Sniffles, we reached maximum
recall rates of 92.4 and 92.6%, respectively (at 44× coverage)
and maximum false positive rates of 78.8% and 97%,
respectively.
chr2
chr9
chr8
chr7
chr9
chr1
chr5
NanoSV
Lumpy
Sniffles
Manta
Delly
Not detected
Deletion
Duplication
Inversion
Interchromosomal
Illumina
MinION
Illumina
MinION
Patient 1
Patient 2
Delly
Manta
Sniffles
Lumpy
NanoSV
Long-insert mate-pair
Tail-to-tail inverted
Head-to-head inverted
Head-to-tail
Tail-to-head
Breakpoint junctions
Breakpoint junctions
Patient 1 Patient 2
18 17
16
15
14
13
59
58
57
149
181
180
179
178
177
176
175
174
173
17
21
711
701
6916
8
16
738373635
34
33
32
31
30
29
28
27
26
25
24
23
22
21
20
19
22
21
20
19
18
17
16
15
23
14
13
12
10
6
10
52
3123
034
33
32
31
30
29
28
27
26
25
24
a
b
Fig. 1 Chromothriptic de novo breakpoint junctions of Patient 1 and Patient 2. a Circos plots for Patient 1 and Patient 2, respectively. For Patient 1, we took
the set of 40 validated de novo breakpoint junctions obtained by Illumina whole-genome sequencing of the patient and its parents. For Patient 2, we
depicted the breakpoint junctions as published recently16. The outer ring of the circos plot shows the chromosomes and the inner ring shows the copy
number changes as revealed by FREEC34 analysis of Illumina whole-genome sequencing data for both patients. Colored lines (arcs) indicate breakpoint
junctions. b SV genotyping comparison across the chromothriptic breakpoint junctions, between Illumina Hiseq data and MinION data, using various tools
tested. The x-axis represents different breakpoint junctions and the y-axis shows different SV calling methods and data sets. The individual breakpoint
junctions are indicated by colors specifying the type of breakpoint junction
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We went on to apply NanoSV to the complex chromosomal
rearrangements data of our patient genomes, and compared
results again against Lumpy23 and Sniffles24 for the MinION data
and Manta20 and Delly19 for the corresponding Illumina data.
For Patient 1, we identified 100% of the 40 validated breakpoint
junctions. Conversely, we discovered 33 (83%) and 31 (78%) of
the 40 de novo breakpoint junction in the call sets from Lumpy
and Sniffles, respectively (Fig. 1b). For Patient 2, NanoSV
detected 24 of the 29 previously described breakpoint junctions.
We investigated further why five variants were missed, using
Sanger sequencing of PCR products of the respective breakpoint
junctions. We found that two out of the five previously published
breakpoint junctions represent a complex combination of more
than two joined segments (Supplementary Fig. 13 and Supple-
mentary Table 2). These short segments were not detectable at the
lower resolution of long-insert jumping libraries that were used in
the previous analyses compared to the long-read capabilities of
MinION sequencing used here16. Based on validation by Sanger
sequencing, we retrieved a total of 32 chromothripsis breakpoint
junctions in Patient 2 and 29 (91%) of these were detected using
NanoSV (Fig. 1b). For the three remaining breakpoint junctions,
insufficient nanopore read coverage hampered proper genotyp-
ing. Nevertheless, for the reads that did span these breakpoints,
split read mappings supporting each of these junctions were
observed. Lumpy and Sniffles detected 9 (28%) and 16 (50%) of
the 32 breakpoints junctions in the nanopore data from Patient 2,
respectively; Manta and Delly detected 19 (59%) and 22 (69%) of
the 32 breakpoint junctions, respectively, in the short-insert
Illumina data of Patient 2. To assess the effect of sequence
coverage on breakpoint junction detection in real data, we
subsampled the Patient 1 data. This produced an estimate of
~14× for the minimum coverage needed to detect all chromo-
thriptic breakpoint junctions (Supplementary Fig. 14).
Unraveling the long-range structure of chromothripsis. It has
been suggested that germline chromothripsis originates from
paternal chromosomes21, but this has previously been inferred
from only a few breakpoint junction sequences or deleted seg-
ments. A thorough validation of the conjecture that the origin of
chromothripsis is exclusively paternal is lacking. Furthermore, the
structure of the chromothripsis rearrangements is typically
inferred from the patterns of breakpoint junctions, under the
assumption that the chromothripsis breakpoint junctions occur
on a single haplotype21,22,26.
We developed a bioinformatic pipeline to augment genome-
wide genetic SNP phasing with nanopore read-based phasing of
SVs (“Methods”). In a first step, we obtained 1.7M heterozygous
SNPs from Patient 1 that were called from Illumina sequencing
data and trio-phased using GATK PBT27 and Patient 1’s parents’
genotypes. Subsequently, each nanopore read was assigned phase
based on a phasing score that takes into account the content and
number of overlapping phase-informative SNPs (“Methods”). Per
chromothripsis breakpoint junction, we obtained between 2 and
11 break-supporting nanopore reads and 85% (195/228) of these
overlapped on average of 9.8 phase-informative heterozygous
SNPs. We similarly phased the nanopore reads that spanned but
did not support the breakpoint junctions (i.e, reference reads).
This analysis demonstrated that all 40 de novo chromothripsis
breakpoint junctions are of paternal origin (Fig. 2). A few
breakpoint supporting reads point to an origin of some
chromothripsis breakpoints on maternal chromosomes. However,
these are all reads with three or less overlapping phase-
informative SNVs, and likely represent artifacts. These results
support earlier hypotheses of a paternal origin of germline
chromothripsis, pointing to a breakage and repair process specific
for male chromosomes occurring either during spermatogenesis
or early zygotic cell divisions21. We were further able to
reconstruct the affected derivative chromosomes of Patient 1 by
following the chain(s) of breakpoint junctions by order and
orientation (Fig. 3a, b). Such a strategy leads to a configuration of
four derivative chromosomes for Patient 1, each containing one
centromere and two telomeric chromosome ends. The chromo-
somal structure obtained by this procedure matched the observed
karyotype (Supplementary Fig. 15).
We further sought to investigate the extent to which the
derived chromosomal structure could be reconstructed from the
MinION sequencing data. We note that a much higher
sequencing depth is required in order to accurately reconstruct
such large chromothriptic regions through diploid assembly. In
order to evaluate the potential of nanopore long-read data to
facilitate future analyses, we pre-phased, as described above, all
the reads that align within the chromothriptic region (i.e.,
~40MB of genomic sequence across four chromosomes) and
used only the reads that are known to originate from the paternal
haplotype and those that could not be assigned phase (i.e., where
the two haplotypes were identical).
We first built contigs by evaluating the read overlaps from the
reference alignment (“Methods”) and obtained contigs that
connect between two to five chromothriptic segments, spanning
up to 2MB of contiguous DNA sequence (Fig. 3c and
Supplementary Fig. 16). Finally, we used Miniasm28 to evaluate
whether such longer, local haplotype structure can be readily
retrieved in a standardized and scalable fashion (“Methods”). The
whole 40MB region was assembled into 178 contigs that were
subsequently aligned against the human reference genome. We
identified three contigs of 241 kb, 469 kb, and 1217 kb in size,
each spanning three to five chromothriptic segments. Segment
order and orientation in each of the three contigs supports the
predicted chromothripsis structure (Fig. 3d and Supplementary
Fig. 17).
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Fig. 2 Phasing of chromothripsis breakpoint junctions. Phasing of MinION
reads overlapping 40 chromothripsis breakpoint junctions in Patient 1. The
x-axis displays each of 40 chromothripsis breakpoint junctions identified in
Patient 1, stratified by allele (alternative and reference). On the left side
only reads supporting the alternative allele are depicted and on the right
side reads supporting the reference allele are shown. The y-axis indicates
the number of reads supporting each allele, for each of the 40 breakpoint
junctions. Legend colors indicate whether the assigned read phase was
paternal, maternal, or unknown
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/s41467-017-01343-4
4 NATURE COMMUNICATIONS |8:  1326 |DOI: 10.1038/s41467-017-01343-4 |www.nature.com/naturecommunications
Evaluation of SV calling in NA12878 nanopore data. Beyond
detection of specific pathogenic SVs, long sequence reads present
unique advantages for SV discovery in human genomes, as it has
been recently shown from data generated on Pacific Biosciences
platforms12,29. Here, we assessed whether MinION sequencing
data could yield comprehensive and high-quality sets of genome-
wide SV calls, as well as whether it may yield any novel SVs
beyond those found through the Illumina sequencing. To evaluate
the performance of NanoSV in a genome-wide analysis, we used
the publicly available MinION data for the NA12878 sample30
and publicly available sets of SV calls, for the same sample, both
from short-read Illumina data31 (referred to as 1KG), as well as
from Pacific Biosciences data13 (referred to as PB). Based on these
calls, we carried out an assessment of sensitivity, as well as
accuracy of our analyses.
We aligned all the fastq MinION R9.4 reads that were
generated using normal ONT library preparation, for the
NA12878 sample (i.e., we did not include ultra-long read data
available for NA1287832). We then restricted the analysis to
chromosome 1 (as a representative subset) and used NanoSV to
produce an initial set of 3957 genotyped SV calls. Manual
inspection of SV candidates within the NA12878 sample as well
as within our patients’ data showed that MinION sequencing and
base calling performs poorly in regions containing homopolymer
stretches, which typically lead to a collapse of the whole region
into a spurious indel call. This is observed across samples, as well
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Fig. 3 Unraveling long-range chromothripsis structure from the nanopore data. a Schematic diagram showing the patterns of breakpoint junctions in Patient
1. The human reference genomic regions that are involved in the chromothriptic event are depicted horizontally for each affected chromosome. The slanted
lines connecting various reference segments represent breakpoint junctions. The orientations of breakpoint junctions are indicated by arrows as shown in
the legend. Black (instead of open) arrows indicate the boundaries of a chromosomal deletion resulting from the chromothripsis, whereas open arrows
indicate double-stranded DNA breaks. b Structure of the chromothriptic derivative chromosomes in Patient 1, as inferred from the orientations and order of
breakpoint junctions shown in a. c Reconstruction of a chromothriptic subregion of chromosome 7, involving five chromosomal segments. Overlapping
aligned reads originating from Patient 1’s paternal haplotype were used. Nanopore reads that are instrumental for segment connectivity are indicated by
black bars. The coverage track has been generated from all paternal reads mapping to the respective chromosomal segments. The underlying derived
chromosome’s structure is illustrated on the bottom. d Haploid assembly results of the chromothriptic region of Patient 1. A 469 kb contiguous assembled
sequence (utg000062l) spans, through 54 segments that align back to the reference genome, the same chromothripsis subregion illustrated in c. The
assembled contig is fragmented into many (54) aligned segments, as Miniasm does not compute a consensus sequence
NATURE COMMUNICATIONS | DOI: 10.1038/s41467-017-01343-4 ARTICLE
NATURE COMMUNICATIONS |8:  1326 |DOI: 10.1038/s41467-017-01343-4 |www.nature.com/naturecommunications 5
as in MinION sequencing of PCR products (Supplementary
Fig. 18). Additionally, we noted that SV calling is similarly
hampered in tandem repeat regions (Supplementary Fig. 18).
Based on these observations, we conservatively discarded calls for
which both ends of the candidate breakpoint junction fall within
genomic homopolymer regions or short tandem repeat stretches,
resulting in a set of 657 SVs in NA12878. We further filtered for
small indels (<40 base pairs) that do not typically result in a split
alignment, resulting in a final set of 654 SVs from the
chromosome 1 nanopore data of NA12878. We ran Lumpy and
Sniffles on the same NA12878 nanopore data and filtered the
resulting SV sets, as well as the gold standard truth sets (1KG and
PB) using the same criteria, so as to enable an informative
comparison. After intersecting the NanoSV call set with 1KG and
PB (“Methods”), we observed a sensitivity of 78% (131 out of 168
1KG SVs) and 88% (292 out of 332 PB SVs), respectively. The
largest proportion (18/37) of the SV calls that were missed in the
comparison to 1KG are multiallelic CNVs, which typically require
dedicated coverage analysis and are absent from the PB data set as
well. We further missed six indels that were close to the threshold
for creating a split read (i.e., 40–50 bp). Identical evaluations of
Lumpy and Sniffles revealed sensitivities of 15% (26/168) and
72% (121/168) in the 1KG set of SVs, and 32% (105/332) and
77% (255/332), respectively, in the PB data set. We note that
Lumpy was designed and tested on short-read paired-end
sequencing data and we used it on long-read data as the
algorithm is conceptually applicable, rather than specifically
tailored.
For all subsequent analyses of the NA12878 sample, we
considered all the SVs also preset in the 1KG or PB data sets as
true positive SV calls (TPs) and any additional SV calls made by
NanoSV as false positive calls (FPs). Out of our set of 654
NanoSV calls, 354 overlap with an SV call in the 1KG or PB data
sets, resulting in an estimated precision of 54%. Similarly, Lumpy
and Sniffles show precisions of 2 and 50%, respectively.
To further improve post-calling filtering, we trained a random
forest model that produces a high-confidence set of SVs, with a
precision beyond the 54% mark. The features based on which the
model is trained are extracted from the aligned sequencing data
and are designed to be sequencing read-depth and read-length
independent, such that the model is applicable to any MinION
sequencing setting (“Methods”). We select as optimal, a random
forest model with 82% precision and 75% sensitivity, on our
training data (Supplementary Fig. 19). The data used for training
are the 354 TP and 300 FP NA12878 SV calls described above.
Genome-wide SV discovery from MinION reads. We went on
to analyse the whole-genome MinION data of Patient 1 and
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jointly, across different SV size bins and stratified by SV type as follows: a deletions, b insertions, c duplications, and d inversions. The NanoSV calls were
intersected with SV calls from other data sources (Illumina data of Patient 1 and Patient 2 and 1KG phase 3 sites). For a, b, the x-axis was trimmed to
1000 bp for visibility and a small number of variants beyond this size are not displayed in the figure. Similarly, for c, the x-axis was limited to 200 bp. e The
repeat content of nanopore-specific insertions. f The repeat content of nanopore-specific deletions. Repeat annotation was obtained from the UCSC repeat
masker table (GRCh37)
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Patient 2. We ran NanoSV and obtained initial call sets of 36,959
and 36,321 SVs, respectively. Filtering for all SVs that do not
overlap homopolymers or simple repeats, we obtain 8578 and
6791 SVs in Patient 1 and Patient 2, respectively. Finally, we ran
the random forest model trained on the NA12878 data, as
described above, and obtained final call sets of 3271 and 3345
SVs, for Patient 1 and Patient 2, respectively.
To further evaluate the robustness of our analysis pipeline, we
performed multiple rounds of orthogonal validation, on a
random sample, spanning all SV classes and size ranges
(“Methods”). We obtained validation status for 274 SVs,
regardless of the random forest prediction outcome, for Patient
1, and 77 SVs predicted as true by the random forest, for Patient
2. Based on these sets, we obtained precision estimates of 95 and
96% for Patient 1 and Patient 2 and a sensitivity estimate of 72%
for Patient 1.
We intersected the SV call sets of Patient 1 and Patient 2 with
calls generated by Lumpy and/or Sniffles. Furthermore, we
performed SV calling on the corresponding Illumina data of both
patients using six tools (Pindel, Manta, Delly, FREEC, Mobster,
and GATK HaplotypeCaller) that are commonly used in human
genome sequencing studies and which represent different
methods to detect SVs (and/or indels) from whole-genome
short-read Illumina sequencing data, that collectively capture
most classes of SVs19,20,33–35. An SV is considered to be
overlapping with the Illumina data set if the nanopore data SV
call matches an SV call in any of the tools used on the Illumina
data (“Methods”). We further considered as overlapping Illumina
data (i.e., “detectable” through short-read sequencing) any
NanoSV-called variant that can be matched within the 1KG SV
and indel sites, respectively (Supplementary Fig. 20)36. Finally, we
annotated the SVs from both patients for overlapping repeat
elements from the UCSC repeat masker track or the DFAM
database (“Methods”).
We identified 14% (944) of SVs in Patient 1 and Patient 2
nanopore data that were not observed in Illumina data nor are
they 1KG variant sites (Fig. 4). A comparison of the two sets of
SV calls shows that nanopore-specific SVs are on average located
at sites with a higher GC content (i.e., than SVs also genotyped
from Illumina data), which are typically hard to sequence with
short-read technologies (Supplementary Fig. 21). The most
frequent class of SVs in the set of 6616 predicted true positive
SVs are deletions (54%), of which 10% (360) are novel variants
detected by nanopore data (Fig. 4a and Supplementary Fig. 22).
We observed that SINE elements were proportionally less
abundant among nanopore-specific deletions (6 vs. 30% among
calls overlapping with Illumina data, Fig. 4f). The major fraction
(91%) of nanopore-specific deletions is not overlapping a repeat
feature, most likely due to our very stringent initial filtering of
simple repeats. In fact, the majority (66%) of the nanopore-
specific deletions are smaller than 200 bp, while only 27% of all
deletions are smaller than 200 bp. Short deletions are known to be
hard to detect using short-read sequencing37. Insertions represent
the largest fraction among the nanopore-specific set of variants
(382, Fig. 4b). We observed a proportional increase in the amount
of LINEs among nanopore-specific insertions compared to calls
overlapping Illumina data (12 vs. 8%), while SINEs are
proportionally underrepresented in nanopore-specific insertions
(36 vs. 42%) (Fig. 4e and Supplementary Fig. 22). Finally, 41% of
all detected (tandem) duplications (337) are novel variants
detected by nanopore data (Fig. 4c).
MinION read-based phasing of SNVs. Phasing genetic variation
is critical for human disease studies38,39. To demonstrate the
potential of long-read nanopore sequencing data for direct read-
based phasing of genetic variation, we employed WhatsHap, an
algorithm that we recently established40,41. Using WhatsHap, we
phased a set of high-quality genome-wide SNVs from both
patients (“Methods”) and obtained haplo-blocks with N50=
126 kb for Patient 1 and N50= 305 kb for Patient 2, respectively.
The distribution of block lengths is shown in Fig. 5a. We were
able to establish 97.5% (96.5%) of all possible phase connections
in Patient 1 (Patient 2), where a phase connection is defined as
the relative phase between two consecutive heterozygous SNVs
(Fig. 5b). For Patient 1, where Illumina sequencing data were
available for the parents, we produced a ground-truth phasing by
genetic haplotyping, that is, by using the SNV genotypes and the
family relationship27. Additionally, we phased both samples using
ShapeIt2 and the 1KG phase 3 reference panel31. Figure 5c shows
pairwise comparisons of the obtained haplotypes, with switch
error rates of 1.7 and 2.3% when comparing read-based and
population-based phasing for Patient 1 and Patient 2, respec-
tively. We observed a lower switch error rate of 1.4% between
trio-based and read-based phasing, which points to a significant
amount of switch errors in the population-based phasing (1.0%
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Fig. 5 Performance of SNV phasing using nanopore reads. a Distribution of phased block lengths resulting from read-based phasing by WhatsHap. Patient 1
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when comparing trio-based vs. population-based phasing).
Therefore, a significant amount of differences between read-based
and population-based phasing is most likely due to errors in the
population-based phasing. Since MinION reads are especially
prone to errors in homopolymer regions, we investigated the
effect of excluding all SNVs in such regions from phasing (see
“Methods” section for a precise definition). This resulted in a
decrease in the number of established phase connections from
97.5 to 91.7% for Patient 1 and from 96.5 to 91.1% for Patient 2
(Fig. 5b) and a decrease in the switch error rate with respect to the
pedigree-based phasing from 1.4 to 0.9% in Patient 1, see Fig. 5c.
This shows that switch errors are indeed often found at such
homopolymer sites and that masking those sites significantly
reduces switch error rates at the expense of only a moderate
reduction of phased variants.
MinION read-based phasing of SVs. While structural variation
has recently been integrated in larger population genetic reference
panels, which enables their imputation for genetic association
studies18,36, building these panels often requires statistical phas-
ing approaches, which drop accuracy for low allele frequency SV
sites. Read-based phasing of SVs using long reads will enhance
our ability to include SVs in high-quality reference panels, where
structural variation is still underrepresented18.
We apply the same methodology as above (i.e., used for
phasing chromothriptic breakpoints) to evaluate genome-wide SV
phasing accuracy. A total of 3.8M MinION reads overlapped one
or more of the 1.7M genome-wide phase-informative SNPs. As
estimated from reads overlapping at least 20 phase-informative
SNPs, an average of 85.2% of the SNPs spanned by a read
consistently support a particular phase assignment, which is in
line with the reported error rate of MinION sequencing data
(Supplementary Fig. 23). A distinction between reads originating
from paternal or maternal haplotypes can be readily made,
particularly if reads overlap with multiple phase-informative
SNPs (Supplementary Fig. 24). We then selected a set of 2389
heterozygous SVs that overlap between Manta (Illumina) and
NanoSV (nanopore) call sets. Each SV was assigned a phase and a
phasing quality (“Methods”), by combining information from all
phase-informative SNPs falling within the breakpoint junction
supporting reads and reference supporting reads, respectively. In
this way, we phased 1909 (78.7%) SVs and could assign 971 and
938 to paternal and maternal chromosomes, respectively. For the
remainder of 480 SVs, spanning reads did not overlap any phase-
informative SNP and therefore a phase could not be assigned to
these SVs. Using the SV phasing produced by PBT as ground
truth, our long-read-based phasing of SVs had an accuracy of
98.5%.
Discussion
In this work, we show the first standalone analysis of MinION
whole-genome sequencing data of human, diploid, patients’
genomes, demonstrating the feasibility of long-read sequencing of
human genomes on the MinION real-time portable nanopore
sequencer. Given the long-read nature of the MinION platform,
we focused the analysis on the detection of clinically relevant SVs,
a diverse category of genetic variation that is often causal to
human genetic disease42. Hundreds to thousands of such patients
are routinely screened annually for pathogenic SVs in clinical
genetic centers, most often by copy number profiling or kar-
yotyping. Although these methods are robust and relatively cost-
efficient, they are not capable of mapping small or copy-balanced
SVs, nor do they provide base-pair resolution accuracy, or the
possibility to resolve complex SVs43.
Here we show that MinION sequencing provides an attractive
alternative approach for genome-wide detection of clinically
relevant SVs, which could be implemented as a clinical screening
tool for patients with congenital phenotypes, such as intellectual
disability44. We developed a robust SV discovery and genotyping
pipeline that can produce SV calls matching any state of the art
precision benchmark (>95% precision). Due to the medium
coverage, some intrinsic nanopore sequencing biases and for
benchmarking purposes, we employ extremely stringent filtering
that results in a good estimated sensitivity (~75%), which can be
further increased through higher sequencing depth, or by relaxing
our post-calling filtering steps.
We were able to extract all known de novo breakpoint junc-
tions for Patient 1 (Fig. 1), even at relatively low coverage (16×).
The long reads identified additional complexity for several
breakpoint junctions of Patient 2. Moreover, 32% (29 vs. 22)
more chromothripsis breakpoint junctions were detected with
MinION compared to short-insert Illumina sequencing. Our
work also supports previous results that revealed many novel SVs
and indels discovered from PB long-read sequencing of haploid
human cells12,29. Through our standalone, genome-wide analysis
of SVs in (diploid) patient genomes, we show that long-read
nanopore data can be readily applied to any research question for
which SVs may play a role. We observed that 14% of the high-
confidence set of SVs in the nanopore data could not be found in
matching Illumina sequencing data (despite extensive variant
calling using six different variant calling methods as well as
comparison to 1KG variant sites). Although this percentage of
novel variants is lower than for previously reported PB data
(89%), this is partly due to our conservative SV calling and post-
calling filtering steps. Long MinION sequencing reads thus enable
a straightforward and homogeneous analysis of SVs, while
retaining a very high accuracy in the final set of variants.
Phasing of genotyped SVs—relevant for mapping disease
associations—is commonly done using statistical methods or by
employing family relationships among sequenced individuals18.
We here devised a computational strategy that allowed accurate
phasing of SVs directly from the long nanopore reads using
flanking (phased) heterozygous SNPs. Read-based phasing of SVs
is advantageous particularly for classes of SVs with a low popu-
lation frequency and for de novo variations. This is exemplified
by the evidence provided here for the paternal origin of all de
novo breakpoint junctions in Patient 1, whereas previous work on
chromothripsis has not provided robust support for the parental
origin of chromothripsis21.
If MinION/ONT data quality and throughput increase at a
similar pace as we have observed recently (Supplementary Figs. 1
and 4), SNV calling and genotyping may be directly performed
based on the nanopore reads. Even though our data are of rela-
tively low coverage, we were already able to obtain a good gen-
otype concordance (96%) with the Illumina-based pipeline, for
existing SNV calls in Patient 1 (not further investigated here).
SNV calling combined with accurate genome-wide phasing, as we
demonstrated here, will enable simultaneous long-read-only
genetic variation discovery and phasing.
Long sequencing reads facilitate personal genome assemblies
and emerging new ways of dealing with genetic variation dis-
covery and representation45,46. Efforts to obtain full-length hap-
lotype resolved chromosomal sequences are continuously
advancing and the combination of multiple long-range sequen-
cing and mapping approaches have recently led to diploid human
genome assemblies with contig N50 size of well over 10MB13,47.
We have not attempted a full human genome assembly using the
MinION reads in this work (primarily due to insufficient cover-
age). However, we were able to separate reads by haplotype,
which formed the basis for a reconstruction of the long-range
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structure of chromothripsis rearrangements. Such information is
essential for interpretation of clinical phenotypes48.
A drawback of current short-read genome sequencing tech-
nology is the need for high capital investment, which often leads
to sequencing infrastructure being located in dedicated sequen-
cing centers. This is associated with a complex logistic workflow
and relatively long turnaround times. Our results show that such
limitations can be overcome by the use of the portable MinION
sequencing technology. Since the start of this project in April
2016, we have seen a tenfold increase in throughput per MinION
sequencing run (Supplementary Fig. 1) and an increase in
sequencing quality to 90% accuracy for high output 1D runs
(450b/s). In practice, this means that 10× coverage of the human
genome can be reached using 10–15 MinION flowcells at a cost of
$5000 to $8000 within 1 week of overall sequencing time.
This work demonstrates the potential of long-read, portable
sequencing technology for human genomics research and clinical
applications. Creating larger catalogs of SVs, in complex repeat
regions and segmental duplications, is a particular challenge in
the coming years. We foresee that population-scale genome
sequencing by ONT or other long-read technology will facilitate
such discoveries, leading to further understanding of the role of
SVs in the human genome in general and in genetic disease in
particular.
Methods
Sample source. The DNA for human genome sequencing in this study was
obtained from two patients with congenital abnormalities and the parents of one of
them. Informed consent for genome sequencing and publication of the results was
obtained from all subjects or their legal representatives. The study was approved by
Institutional Review Boards of San Luigi University Hospital and Brigham and
Women’s Hospital and Massachusetts General Hospital. Both patients have been
previously described by Redin et al.16.
DNA extraction. DNA of Patient 1 was obtained from either peripheral blood
mononuclear cells (PBMCs) derived from blood and from renal epithelial cells
obtained from urine. Renal cells were cultured up to eight passages as reported
previously49. Cells were harvested after reaching confluency by trypsinization with
TrypLE Select (Thermo Fisher Scientific) and centrifugation at 250×g for 5 min.
DNA from the parents was obtained from PBMCs. PBMCs were collected by a
ficoll gradient. In brief, the blood was diluted 4× with phosphate-buffered saline
(PBS). Subsequently 13 mL of Histopaque®-1077 (family 1; Sigma-Aldrich
10,771–500ML) was added per 35 mL of diluted blood. The resulting mixture was
centrifuged at room temperature for 20 min at 900×g, followed by recovery of the
PBMC layer. PBMCs were washed twice using PBS, centrifuged at 750×g for 5 min
and resuspended in PBS with 50% DMSO. For Patient 2, DNA was obtained from a
lymphoblastoid cell line, which has not been tested for mycoplasma contamination.
The cell line was authenticated by whole-genome sequencing. DNA extraction
from cultured cells and PBMCs was performed using DNAeasy (Qiagen) or
Genomic-tip (Qiagen) according to the manufacturer’s specifications with exclu-
sion of vortexing to maintain DNA integrity.
MinION library preparation and sequencing. Isolated DNA was sheared to
~10–20 kb fragments using G-tubes (Covaris). Subsequently, genomic libraries
were prepared using the Oxford Nanopore Sequencing kit (SQK-MAP006 for R7
or SQK-NSK007 for R9), the Rapid library prep kit (SQK-RAD001), or the 1D
ligation library prep kit SQK-LSK108. A 0.4× (instead of 1×) ampure cleanup was
introduced after the FFPE DNA repair and the end-repair steps in the protocol to
ensure removal of small DNA fragments. Genomic libraries were sequenced on
R7.3, R9 and R9.4 flowcells followed by base calling using either Metrichor
workflows or MinKnow software. For Patient 2, we introduced a DNA size
selection step prior to library preparation using the Pippin HT system (Sage
Science).
Illumina whole-genome sequencing. Genomic DNA of the patients and the
parents was sheared to 400–500 bp fragments using the Covaris. Subsequently,
genomic libraries were prepared using the nano library preparation kit. Genomic
libraries were sequenced on an Illumina HiSeq X instrument to a mean coverage
depth of ~30×.
Nanopore data mapping. FASTQ files were extracted from base-called MinION
sequencing data using Poretools (version 0.6.0)50. Subsequently, fastq files were
used as input for mapping by LAST (version 744)17, against the GRCh37 human
reference genome. Prior to mapping the full data set, we used the last-train function
to optimize alignment scoring parameters using a sample of 1200 nanopore reads.
Nanopore sequencing data were also mapped using BWA-MEM with the -x ont2d
option, as required by Lumpy and Sniffles. MinION 2D runs can produce 2D
sequence reads, i.e., data where both forward and reverse reads of a DNA
duplex are collapsed into a single sequence read, which produce three sequences in
a fastq file, termed 1D template, 1D complement, and 2D. Therefore, we filtered the
LAST and BWA BAM files by only retaining one of these three “versions” for each
read based on the following order of preference: 2D> 1D template> 1D
complement.
Illumina data mapping. Illumina HiSeq X ten data were mapped to the
reference genome using BWA-0.7.5a using “BWA-MEM -t 12 -c 100 -M -R”.
Reads were realigned using GATK IndelRealigner51 and deduplication was
performed using Sambamba markdup52. Short indels and SNPs were genotyped
using GATK HaplotypeCaller, jointly for the Patient 1 trio and individually for
Patient 2.
Analysis of MinION sequencing error rates. We generated a set of 1,064,470
random positions on chromosome 1 and excluded sites that were regarded as
polymorphic based on Illumina GATK variant calling. For each of the remaining
positions, the mismatch rate, deletion rate, and insertion rate were calculated using
samtools mpileup. All positions were overlapped with a bed file consisting of
homopolymers longer than or equal to 5 bp. Additionally, we retrieved the simple
repeat track from the UCSC table browser for overlapping all genomic positions
with simple repeats. GC content was calculated using a window size of 10 bp
surrounding each genomic position.
NanoSV algorithm. The NanoSV algorithm developed here (https://github.com/
mroosmalen/nanosv) uses LAST BAM files as input. We did not use BWA-MEM
alignments as NanoSV input, because the reads are not always split in non-
overlapping segments. More precisely, we observed that the following two (over-
simplified) CIGAR strings may be produced, for two aligned segments originating
from the same sequencing read: 6M4S and 4S6M, respectively. While at least some
of these alignments are marked as secondary by BWA and can be simply discarded
from the analysis, we found that the LAST alignment splitting of the same reads
leads, in some cases, to identification of otherwise high-confidence structural
variants. This observation was not further investigated for the purpose of this
project. See Supplementary Fig. 25 for a real example extracted from our data.
NanoSV uses clustering of split reads to identify SV breakpoint junctions. In a
first step, all mapped segments of each split read are ordered based on their
positions within the originally sequenced read. The aligned read may contain gaps
between its aligned segments, i.e., parts of the read that do not align anywhere on
the reference genome, for example, due to insertions (Supplementary Figs. 10 and
11) or simply due to low-quality sequencing.
Let tuple x= (c,s,e,k) describe an aligned sequence segment, where the
chromosome and genomic start and end coordinates of the segment are specified
by c, s and e, respectively, and the mapping orientation by k∈ {+,−}. The
coordinates s and e represent the start (lowest) and end (highest) coordinate of the
mapped segment on the reference genome. Now, read Ri can be described in terms
of the ordered list of aligned segments and alignment gaps Xi= [u1, x1, u2, x2, u3,
…, xN, uN+1], where the ordering is determined based on their occurrence in the
read, u is the gap (i.e., unaligned sequence preceding segment x) and N is the total
number of aligned segments for read R. Alignment gaps are defined as read
segments that are either unaligned or segments that fail to reach the mapping
quality threshold Q1 (default: 20). The size of an unaligned segment is denoted as
|u|, and can be zero in case two adjacent segments align successfully.
Any two consecutive aligned segments [xn, un, xn+1] in a read define a candidate
breakpoint junction.
We further aggregate evidence from different reads supporting the same
candidate breakpoint junction. This is achieved by clustering all candidate
breakpoint junctions that have the same orientation and have start and end
coordinates that are in close genomic proximity. In order to facilitate clustering of
reads that cover the same breakpoint junction but that map to opposite strands of
the reference human genome, order and orientation of the aligned segments is
reverse complemented if for the genomic coordinates {p,q} mapping to the two
closest bases of segments xn and xn+1, respectively, within a given sequence read Rx,
at least one of the following conditions is met:
1. p and q are on the same chromosome and p−q> 0
2. p and q are on different chromosomes and p has a higher chromosome
number
The clustering is initialized by assigning each pair of consecutive aligned
segments [xn, un, xn+1] to a separate cluster. The resulting clusters are then
recursively merged. Any two clusters (Cx and Cy) are merged if and only if, there
exists a candidate breakpoint junction tuple (xn, xn+1)∈ cluster Cx and a candidate
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breakpoint junction tuple (ym, ym+1)∈ cluster Cy, such that the following
conditions are met:
xn cð Þ ¼ ymðcÞ
segments n; mmap to same chromosomeð Þ
xnþ1 cð Þ ¼ ymþ1ðcÞ
segments nþ 1; mþ 1map to same chromosomeð Þ
xn kð Þ ¼ ymðkÞ
segments n;m have same orientationð Þ
xnþ1 kð Þ ¼ ymþ1ðkÞ
segments nþ1;mþ1 have same orientationð Þ
minx;y xnðeÞ  ym eð Þj jð Þ  d
if xn kð Þ ¼ þ n;m segment ends are in close proximityð Þ
minx;y jxnðsÞ  ym sð Þjð Þ  d
if xn kð Þ ¼  n;m segment starts are in close proximityð Þ
minx;y jxnþ1ðsÞ  ymþ1 sð Þj
   d
if xnþ1 kð Þ ¼ þ nþ1;mþ1 segment starts are in close proximityð Þ
minx;y jxnþ1ðeÞ  ymþ1 eð Þj
   d
if xnþ1 kð Þ ¼  nþ1;mþ1 segment ends are in close proximityð Þ
Where d is the threshold that we set for the maximum distance between the
alignment coordinates of two segments if they are to be considered as supporting
the same breakpoint junction (default: 10 bp). Iterative clustering continues until
no more clusters can be merged. Each final cluster represents one candidate SV,
which is described by tuple b = (c1,c2,p1,p2,k1,k2,g), with p1, p2 the medians of the
start and end coordinates of all candidate breakpoint junctions contained in the
cluster, c1, c2 the chromosomes associated to these coordinates and k1, k2 the
orientation of the breakpoint junction. Finally, the gap size g denotes the median
size of the unaligned segments un, between the two consecutive aligned segments xn
and xn+1 of all the tuples within the respective cluster.
A true SV is called when a candidate SV is supported by more than T reads
(default: 2). Moreover, SVs with median mapping quality of the supporting reads
not exceeding Q2 are still reported, but flagged as “MapQual” in the VCF FILTER
field. SV types can be determined from tuple b. Breakpoint junctions, where c1 and
c2 point to different chromosomes, are considered interchromosomal SVs (e.g.,
chromosomal translocations), which can have one of four possible orientations
(3′–3′, 3′–5′, 5′–5′, 5′–3′). Similarly, breakpoint junctions, where c1 and c2 point to
the same chromosome, are intrachromosomal SVs, which can have one of four
possible orientations (inversion type= 3′–3′ or 5′–5′, deletion/insertion type=
3′–5′, tandem duplication type= 5′–3′). Insertions and deletions are discerned
based on the relation between the gap size, g, and the reference length l = |p1−p2|,
where an insertion is called if g> l and a deletion is called when g<= l
(Supplementary Fig. 11).
We only consider two possible alleles for each SV candidate (present=ALT/
absent= REF). The reads supporting the alternative allele contain the segments
constituting the breakpoint junction cluster. We consider as supportive of the
reference allele all reads for which there is an aligned segment crossing one of the
ends of the breakpoint junction (or both). More formally, a read is defined as
crossing a breakpoint if it contains at least one aligned segment xn for which holds:
(p1−xn(s)> 100 ∧ xn(e)−p1> 100) ∨ (p2−xn(s)> 100 ∨ xn(e)−p2> 100). Reads not
supporting the reference allele according to this definition are ignored. SV
genotypes (homozygous alternative, heterozygous, homozygous reference, not-
called) are assigned based on a Bayesian likelihood similar to the one used (and
formally defined) by the SVTyper23. SV calls are reported in VCF format following
the VCF standards as maintained by samtools specifications53. To facilitate
reporting of complex SV types, such as inversions or reciprocal translocations,
individual breakpoint junctions that bridge the same chromosomal regions, but are
opposite in orientation (e.g., 3′–3′ and 5′–5′ for inversions), are linked using an
identifier.
Nanopore data SV calling. We run NanoSV on the MinION data of each patient
using the default parameters: “-t 8 -s 10 -p 0.70 -m 20 -d 10 -c 2 -f 100 -u 20 -r 300
-w 1000 -n 2 -q 80 -i 0.80 -g 100 -y 20”. We discarded all sites where the alternative
allele count was 0 in the resulting genotype (i.e., HOM_REF) and further filtered
the resulting call sets for SVs tagged as “Cluster”. The “Cluster” VCF INFO-field
tag is added to all SV calls, which lie inside a (default) 1000 bp region containing
three SVs or more. These clusters of SVs are most likely either sequencing errors or
located in highly repetitive and/or decoy regions of the human reference. We used
Lumpy23 and Sniffles24 (specifically designed for ONT and PB data) to call SVs in
both samples using BWA-MEM alignments (instead of LAST alignment, as per
requirement of the respective callers) of the same data and settings that match our
own (liberal) NanoSV settings as closely as possible, as follows. For Lumpy:
“-mw 2 -tt 0 -e”, requiring that at least one read supports each candidate break-
point and clustering breakpoints within 10 bp (back_distance= 10). For Sniffles:
“-s 2--max_num_splits 10 -c 0 -d 10”24. At the time of our analysis, SVTyper was
not supporting nanopore reads (i.e., it required paired-end reads), therefore we
considered the Lumpy, ungenotyped, SV candidate sites as final calls for all sub-
sequent analyses/comparisons. This implies that all sensitivity estimates for Lumpy
are upper bounds and that precision estimates are most likely underestimated.
Simulation of nanopore reads containing structural variants. We took the
human reference chromosome 1 sequence (GRCh37) and introduced 501 break-
points, followed by random reshuffling of chromosomal segments into a new
sequence. The breakpoints were introduced in a 20MB region
(chr1:51707947–71707947), similar in size as a typical chromothripsis region.
Subsequently, NanoSim25 was used to simulate nanopore reads. We used 400
random reads from Patient 2 to build the error profiles for the simulated reads.
Simulated read sets were generated for both the reshuffled chromosome 1 and the
reference chromosome 1, in order to be able to introduce heterozygous structural
variations in the simulated read data. Simulated reads were mapped using LAST
and BWA, followed by SV calling using NanoSV, Lumpy and Sniffles, as described
above. We performed downsampling of the reads to evaluate the effect of coverage
on simulated breakpoint detection. Four of the randomly generated SV breakpoints
produced small events (~40–50 bp), for which the LAST alignment does not result
in a split read; these events were missed by NanoSV, regardless of the coverage
used.
Random forest variant filtering model. We trained a random forest (RF) model
that we subsequently used to filter out false positive SV calls from our nanopore
data, such that we obtained a high precision set of variants for downstream ana-
lysis. The training data for our model consists of 354 true positive (TPs) SVs and
300 false positives (FPs). These 654 training data SVs are the NA12878 SV gen-
otypes described in “Results” section, where any SV overlapping any of 1KG or PB
data sets is considered a TP and all other SVs are considered FPs. Our training data
are conservative in the sense that while all SVs considered TPs are based on
previously curated data, we denote false positive SVs solely by overlap with other
(different data) data sets (i.e., we performed no validation on NA12878 to evaluate
if all/most novel variants that we find are indeed FPs).
We supply the following features to the RF model (where side 1 and side 2 refer
to the lowest and highest genomic coordinates of a breakpoint junction,
respectively; and the mean decrease Gini for each feature—proportional to the
efficiency of splits in the model based on the respective feature—following in bold):
● Mapq1: average mapping quality over all reads supporting side 1 of the
breakpoint junction (5.78)
● Mapq2: average mapping quality over all reads supporting side 2 of the
breakpoint junction (4.39)
● Pid1: average percent identity (i.e., to the reference) over all reads supporting
side 1 of the breakpoint junction (27.10)
● Pid2: average percent identity (i.e., to the reference) over all reads supporting
side 2 of the breakpoint junction (31.73)
● Cipos1: genomic distance from the median start position of the SV to the
lower bound of its associated confidence interval (21.22)
● Cipos2: genomic distance from the median start position of the SV to the
upper bound of its associated confidence interval (i.e., confidence interval
width= cipos1 + cipos2) (17.08)
● Plength1: average proportion of the aligned segment (i.e., relative to the entire
read length), across all segments supporting side 1 of the breakpoint junction
(32.02)
● Plength2: average proportion of the aligned segment (i.e., relative to the entire
read length), across all segments supporting side 2 of the breakpoint junction
(43.44)
● Ciend1: genomic distance from the (median) end position of the SV to the
lower bound of its associated confidence interval (17.73)
● Ciend2: genomic distance from the (median) end position of the SV to the
upper bound of its associated confidence interval (i.e., confidence interval
width= ciend1 + ciend2) (26.72)
● TotalCovNorm: depth coverage summed across both ends of the breakpoint
junction, divided by the average depth of coverage across the sample (13.44)
● Vaf: percentage of the reads spanning either end of the breakpoint junction
that support the variant allele (i.e., the presence of a breakpoint junction)
(82.81)
We found that most of our selected features were statistically significantly
different across the sets of TPs and FPs, respectively (Supplementary Fig. 26), thus
informative to our model.
The precision-recall curve of the model, and its 95% confidence interval,
displayed in Supplementary Fig. 19 is derived from 100 bootstrapping runs, where
the whole training data were split into 90–10% train-test subsets. The optimal
operating point was chosen at 82% precision and 75% recall, and the final model
used was trained again using all the training data available.
We compared the distributions of the random forest features used, across the
training data of NA12878 and the test data of Patient 1 and Patient 2, respectively,
and observed no statistically significant difference (Supplementary Fig. 27), We
note that some difference should in fact be expected in the Patient 1 comparison, in
the average read percent identity related features used (pid1 and pid2), given the
different chemistries and nanopores used to generated these data.
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Illumina data SV calling. SV calling for Illumina data was done using Manta20,
Delly19, FREEC34, Mobster33, and Pindel35. For Manta we used version 0.29.5 with
standard settings, for Delly we used version 0.7.2 with “-q 1 -s 9 -m 13 -u 5”, for
FREEC we used version 7.2 with window= 1000, for Mobster we used version 0.1.6
with standard settings (Mobster properties template), for Pindel we used version
v0.2.5b8 with standard settings and excluding regions represented by the UCSC
GRCh37 gap table using the -c option. Homozygous reference calls (genotype = 0/
0) were omitted from the call sets for each of these tools.
PCR, primer design, and SV validations. Primers for breakpoint junction vali-
dation were designed using Primer3 software54. Breakpoint junction coordinates
and orientations were used as input for primer design. Amplicon sizes varied
between 500 and 1000 bp. PCR reactions were performed using AmpliTaq gold
(Thermo Scientific) under standard cycling conditions. PCR products were
sequenced using MiSeq (TruSeq library preparation, Illumina), Sanger sequencing
(Macrogen), or MinION sequencing (2D library preparation and sequencing).
We performed extensive and heterogeneous validation on the SV calls of Patient
1, in order to obtain a thorough and reliable characterization of our data set and an
informative comparison to standard approaches. We first randomly selected 384
NanoSV candidate calls (uniformly distributed across the observed size-range of
SVs) from the call set of Patient 1 and performed validation with Illumina MiSeq.
We further selected 400 candidate calls (uniformly distributed across the observed
size-range of SVs) exclusively from the nanopore-specific SV calls and validated
them. Deep coverage MinION sequencing was used for this second round of
validation, under the assumption that a long-read accessible-only set of variants
would be less likely to validate using the short-read Illumina sequencing. A third
round of validation was performed, also by MinION deep coverage sequencing, on
a set of 192 non-random variants; namely, 96 variants were expected to be true
positive SV calls and 96 false positive SV calls, as of an initial attempt to build a
discriminative model. Upon inspection of these validation results, SVs falling
within homopolymer stretches (see above) and/or short tandem repeats (UCSC
tandem repeat table) were considered unreliably genotyped (i.e., even in the
validation data) and were subsequently discarded from the data set altogether (see
main text—“Results” section).
All of the above three rounds of validation are thus restricted to the sites that
fall outside homopolymers and/or short tandem repeats and SVs for which we did
not obtain a specific PCR product are discarded. This is the subset that is referred
to as validation data throughout the text, when evaluating precision and it consists
of 274 SVs (185 true positives and 89 false positives).
Finally, we selected 14 large inverted breakpoint junctions (>1000 bp) plus 82
randomly selected SV candidates, all of which were predicted as true by the
random forest model from Patient 2. We performed PCR for each of these 96 SV
breakpoint junctions and sequenced the resulting amplicons using deep coverage
MinION sequencing. We were able to successfully produce and sequence
amplicons for 77 of the variants, and 74 of them validated. Out of the 14 large
inverted breakpoint junctions, eight produced a PCR product and seven of these
were validated as true.
A structural variant was considered validated as a true positive if there exists an
SV call, in the validation SV call set, that overlaps (in the meaning described below)
the original SV validation candidate. The validation SV call set is produced
similarly to the initial analysis, where Manta is used for genotyping SVs in the
MiSeq validation data and NanoSV is used for the nanopore data, respectively, with
the note that deep coverage (i.e., ~1000 for MiSeq and MinION runs) enables
accurate genotyping.
Annotation of repeat elements. All deletions from our NanoSV call set were
annotated as overlapping a repeat element, if the sequence of the variant overlaps
an entry of the repeat masker table of UCSC (GRCh37). For all NanoSV variants
reported as insertions, we extracted the inserted sequence as identified in each
supporting nanopore read, used Muscle55 to generate a multiple sequence align-
ment for all the sequences supporting the same insertion and obtained a consensus
sequence by a simple majority vote. Subsequently, we interrogated the DFAM56
database and annotated all insertions which contained sequence of a repeat
element.
Calculating overlap between SV data sets. To calculate the intersection between
SV call sets, we considered each SV call as a set of breakpoint junction start and
end coordinates s and e, and orientation k. For any SV call i, each breakpoint
junction coordinate (si and ei) is the median of an associated confidence interval,
(si,l,si,h) and (ei,l,ei,h), respectively, as derived from the evidence cluster Ci. SV calls i
and j are overlapping if the confidence intervals of their start and end coordinates
are closer together than 101 bp. For SVs smaller than 1000 bp (excluding inser-
tions), we additionally required that SVs overlap each other with a reciprocal
overlap of at least 70%, otherwise, considering the 100 bp margin that we use when
comparing breakpoint junction borders, different SVs that happen to be in geno-
mic close proximity may, incorrectly, be considered the same event.
GC bias. The GC content (i.e., percentage of guanine or cytosine bases within a
certain DNA sequence) was computed for 100,000 5 kb intervals of the reference
genome (build GRCH37). These intervals were chosen such that they do not
overlap sequencing gaps in the reference, as defined in the UCSC table browser,
including telomers, centromeres, and other gaps. The average depth of coverage
across each interval was then computed from the HiSeq alignment data and the
MinION alignment data, respectively (stratified by sequence reads tagged as
“passed” and “failed” by the Metrichor base calling for Patient 1). The GC content
was binned into 30 uniformly spread bins, between the minimum and the max-
imum GC content derived from the data. Six GC content bins were discarded—i.e.,
those where GC content <0.26 or GC content >0.66—as too few sampled intervals
fell within these bins and a coverage distribution cannot be robustly estimated (i.e.,
1–18 intervals per bin, Supplementary Fig. 6).
A linear regression model with average coverage as the dependent variable and
GC content as the independent variable was fitted, in order to quantify the GC bias
of the two sequencing technologies, respectively. The average coverage values were
normalized (0 mean, 1 variance) for Illumina and MinION data, respectively,
because of the different sequencing average depth of coverage, such that the
regression coefficients for the two technologies be comparable (i.e., the resulting
regression coefficients express the number of standard deviations that the coverage
varies, per GC content percentage).
Genetic phasing of variants from Illumina sequencing data. We used the
Illumina whole-genome sequencing data of Patient 1 and both its parents to obtain
a high-confidence set of phased genotypes (including SNVs, short indels, and SVs),
against which we subsequently evaluated the nanopore data analysis. We used
GATK PhaseByTransmission (PBT)27 to correct genotypes based on trio infor-
mation and to obtain deterministic phasing for most loci. PBT settings were:
“-prior 0.000001 -useAF GT -af_cap 0.0001”. The PBT-phased SNVs were used to
evaluate the genome-wide read-backed phasing from nanopore data as well as for
phasing the nanopore reads and the PBT-phased SVs were used to evaluate the
nanopore read-backed phasing of the SVs (i.e., evaluation was limited to the SVs
detected in both nanopore and Illumina data). PBT was run with a de novo
mutation prior of 10e-6 and supplied with the population allele frequencies of 1KG
phase 3 European population.
Nanopore read-based phasing of SNVs using WhatsHap. For both patients, all
bi-allelic heterozygous SNVs were phased from the aligned MinION reads using
WhatsHap40,41 (version 0.13 + 21.g45bd7f8, command line “whatshap phase--
distrust-genotypes--reference <ref.fasta> <variants.vcf> <reads.bam>”), i.e., with
realignment mode enabled. That is, reads were realigned against reference and
alternative alleles at variant sites, which is critical for phasing performance of noisy
long reads41. For comparison purposes, we used SNV genotypes to obtain a
population-based phasing with respect to the 1KG phase 333 reference panel by
running ShapeIt with default parameters. We excluded from the comparison all
variants that fell within homopolymer runs longer or equal to 5 bp, due to both
genotyping accuracy, but mostly because of the known drop in sequencing
accuracy of MinION reads for longer homopolymer sequences. The homopolymer
bed-track used was computed genome-wide, incorporating a 1 bp border around
the homopolymer, such that relatively frequent sequences of the form
“XXXXXYZZZZZ” be merged into one homopolymer region for the final result.
Phasing of nanopore reads and SVs. Individual nanopore reads from Patient 1
were phased using a set of 1.7M heterozygous SNVs that were genetically phased by
GATK PBT27. Individual nanopore reads were phased using the genetically phased
SNVs by determining the base call and corresponding base quality at each SNV
position within each read. Let b(i) and q(i) be the base call and associated quality
value for some SNV i in some read under evaluation. Further let BM(i) and BP(i)
be the maternal and paternal alleles, respectively (i.e., as phased by PBT), for SNV i.
The information from all SNVs spanned by a read is then aggregated and the
likelihood that read r originates from the paternal or the maternal haplotype,
respectively, is computed:
Lp rð Þ ¼
Yn
i¼1
P bðiÞ BP ið Þjð Þ
Lm rð Þ ¼
Yn
i¼1
P bðiÞ BM ið Þjð Þ
Where n is the total number of SNVs that read r overlaps and
P b ið Þjbaseð Þ ¼ 1 10q ið Þ10 ; if b ið Þ ¼ base
P b ið Þ basejð Þ ¼ 10q ið Þ10 ; if b ið Þ≠base
Is the probability that a read supports a specific phased allele at an SNV. The
likelihoods that the SV resides on the paternal or the maternal haplotype,
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respectively, are then computed:
Lp SVð Þ ¼
YRSV
r¼1
Lp rð Þ
Lm SVð Þ ¼
YRSV
r¼1
Lm rð Þ
Where Rsv denotes the set of all reads supporting the breakpoint junction. The two
likelihood scores are then transformed to probabilities (i.e., normalized to sum up
to 1) and phase for the set of breakpoint junction supporting reads is assigned as
indicated by the highest likelihood score. Phase is assigned identically to the set of
reference supporting reads spanning the breakpoint junction.
An SV is then considered phased if the two phases, for the set of breakpoint
supporting reads and reference supporting reads, respectively, correspond to
different parental haplotypes and the (phred scaled) phasing posterior quality is
defined as:
PP ¼ 10 ´ log10 max Lp SVð Þ; Lm SVð Þ
 
´ max Lp REFð Þ; Lm REFð Þ
  
Reconstructing the chromothripsis from alignment overlaps. To obtain evi-
dence for the long-range structure of the chromothripsis breakpoint junctions in
Patient 1, we first extracted the set of (aligned) nanopore reads that span the
chromothripsis regions on chromosomes 1, 7, 8, and 9. Separation of reads by
phase was done as described above. The mapped segments were ordered by left
genomic mapping coordinate of each segment to produce an ordered list of seg-
ments L={s(1), s(2), …, s(n)}, from all reads jointly. We then built an oriented
graph, where each aligned segment in L is initially a node and nodes were itera-
tively merged as follows: Let i and j represent the start (left) and end (right)
coordinate of each segment (i.e., or, subsequently, nodes). In order for s(x) to be
merged into a node s(y), there must exist at least two other segments s(z) and s(t)
supporting the same node, such that (s(z)j−s(x)i)>=20 bp and (s(t)j−s(x)i)>=20 bp.
Edges were then added, to the final, reduced set of nodes, by evaluating each read’s
segmentation across supported nodes. Namely, an edge is added between any two
nodes for which there is a read such that one segment of the read supports one
node and another segment of the same read supports the other node. Each edge
was then weighted by the number of reads supporting that connection.
Finally, contigs were built by evaluating all maximal length paths through the
graph, where only edges of weight at least two are considered and branching is
resolved in a greedy way, by selecting the maximum weight path at each step.
Using the above algorithm, individual breakpoint junctions were connected
together, providing support for the order of the joined segments in the
chromothripsis chromosomes of Patient 1.
Assembly of MinION sequencing data. Nanopore reads of Patient 1 were
separated into three bins by phase, as described above. The reads that were assigned
a paternal phase and the unphased reads were used as input for de novo assembly
using Miniasm28, with settings: minimap -S -w 5 -L 100 -r 500 -m 0 and miniasm
-c 1 -m 100 -h 20000 -s 100 -r 1,0 -F 1. The mentioned parameters were found to
produce the longest contigs from our data. These Miniasm contigs were subse-
quently aligned to the human reference genome (GRCh37) using LAST, with
settings: -s 2 -T 0 -Q 0 -p [last_parameters]. The last_parameters were obtained as
described above (i.e., the same used for aligning the initial MinION data of Patient
1 and Patient 2). LAST aligments (SAM format) were processed by custom scripts
to evaluate the presence of chromothripsis segments from Patient 1 based on
chromosomal coordinate overlap.
Data availability. Illumina and nanopore whole-genome sequencing data used in
this study can be accessed through the European Genome-phenome Archive under
accession number EGAS00001002333. All other relevant data are available from
the corresponding author on request.
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